Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function
Washington University School of Medicine
Washington University School of Medicine
GlaxoSmithKline
Taiho Oncology, Inc.
Takeda
Astex Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, LLC
Celgene
BTG International Inc.
Bayer
Massachusetts General Hospital
Acrotech Biopharma Inc.
Celgene
National Cancer Institute (NCI)
Celgene
Dartmouth-Hitchcock Medical Center
GlaxoSmithKline
Amgen
Bayer
Novartis
Merck Sharp & Dohme LLC
AstraZeneca
Merck KGaA, Darmstadt, Germany
Astellas Pharma Inc
Newron Pharmaceuticals SPA
National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health Clinical Center (CC)